Login or sign up
For business

Iterion therapeutics

4.3Β· 11 reviews
Average ratingGreat
4.3/ 5

Based on 11 reviews

545%
436%
318%
20%
10%
Ask AI

Ask AI about Iterion therapeutics

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Trevor Hellebuyck
Reviews 1

The experience with Iterion Therapeutics has been average. The company provides good products and services, but there is room for improvement. The website is user-friendly and informative. However, the customer support could be more responsive. Overall, a decent experience.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Iterion therapeutics

Iterion Therapeutics is a venture-backed, clinical-stage biotechnology company that develops novel targeted cancer therapeutics. The company’s lead product, Tegavivint, is a potent and selective inhibitor of the Wnt/b-catenin signaling pathway, implicated in cell proliferation, differentiation, immune evasion, and stem cell renewal. Tegavivint demonstrates pre-clinical in vivo efficacy in several cancer models including desmoid tumors, acute myeloid leukemia (AML), osteosarcoma, and a range of solid tumor types. The Company is currently enrolling a Phase I clinical study of Tegavivint in patients with desmoid tumors at multiple clinical centers in the United States and Canada.

It was founded in 2010 and is headquartered in Houston, Texas.

Address
2450 holcombe boulevard
Categories
Biotechnology